These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36258218)

  • 1. Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports.
    Dewaswala N; Chen D; Bhopalwala H; Kaggal VC; Murphy SP; Bos JM; Geske JB; Gersh BJ; Ommen SR; Araoz PA; Ackerman MJ; Arruda-Olson AM
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):272. PubMed ID: 36258218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NATURAL LANGUAGE PROCESSING BASED MACHINE LEARNING MODEL USING CARDIAC MRI REPORTS TO IDENTIFY HYPERTROPHIC CARDIOMYOPATHY PATIENTS.
    Sundaram DSB; Arunachalam SP; Damani DN; Farahani NZ; Enayati M; Pasupathy KS; Arruda-Olson AM
    Proc Des Med Devices Conf; 2021 Apr; 2021():. PubMed ID: 35463194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
    Habib M; Adler A; Fardfini K; Hoss S; Hanneman K; Rowin EJ; Maron MS; Maron BJ; Rakowski H; Chan RH
    JACC Cardiovasc Imaging; 2021 May; 14(5):947-958. PubMed ID: 33248971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing.
    Moon S; Liu S; Scott CG; Samudrala S; Abidian MM; Geske JB; Noseworthy PA; Shellum JL; Chaudhry R; Ommen SR; Nishimura RA; Liu H; Arruda-Olson AM
    Int J Med Inform; 2019 Aug; 128():32-38. PubMed ID: 31160009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy.
    Śpiewak M; Kłopotowski M; Mazurkiewicz Ł; Kowalik E; Petryka-Mazurkiewicz J; Miłosz-Wieczorek B; Klisiewicz A; Witkowski A; Marczak M
    Sci Rep; 2020 Dec; 10(1):21054. PubMed ID: 33273702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.
    Suk T; Edwards C; Hart H; Christiansen JP
    Heart Lung Circ; 2008 Oct; 17(5):370-4. PubMed ID: 18562248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Language Processing for the Ascertainment and Phenotyping of Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy on Echocardiogram Reports.
    Berman AN; Ginder C; Sporn ZA; Tanguturi V; Hidrue MK; Shirkey LB; Zhao Y; Blankstein R; Turchin A; Wasfy JH
    Am J Cardiol; 2023 Nov; 206():247-253. PubMed ID: 37714095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
    Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence study on left ventricular function among normal individuals, hypertrophic cardiomyopathy and dilated cardiomyopathy patients using 1.5T cardiac cine MR images obtained by SSFP sequence.
    Guo J; Lu H; Chen Y; Zeng M; Jin H
    Br J Radiol; 2022 May; 95(1133):20201060. PubMed ID: 35084208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy: Equivalent Detection by Magnetic Resonance Imaging and Contrast Echocardiography.
    Lee DZJ; Chan RH; Montazeri M; Hoss S; Adler A; Nguyen ET; Rakowski H
    J Am Soc Echocardiogr; 2021 Dec; 34(12):1262-1272. PubMed ID: 34375676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.